- Home
- BNZI vs FBRX Comparison
BNZI vs FBRX Comparison
Compare BNZI & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNZI
- FBRX
- Stock Information
- Founded
- BNZI 2016
- FBRX N/A
- Country
- BNZI United States
- FBRX United States
- Employees
- BNZI N/A
- FBRX N/A
- Industry
- BNZI
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- BNZI
- FBRX Health Care
- Exchange
- BNZI Nasdaq
- FBRX Nasdaq
- Market Cap
- BNZI 11.5M
- FBRX 154.5M
- IPO Year
- BNZI N/A
- FBRX N/A
- Fundamental
- Price
- BNZI $2.12
- FBRX $12.33
- Analyst Decision
- BNZI Strong Buy
- FBRX Strong Buy
- Analyst Count
- BNZI 1
- FBRX 3
- Target Price
- BNZI $240.00
- FBRX $68.00
- AVG Volume (30 Days)
- BNZI 337.9K
- FBRX 75.9K
- Earning Date
- BNZI 11-13-2025
- FBRX 11-13-2025
- Dividend Yield
- BNZI N/A
- FBRX N/A
- EPS Growth
- BNZI N/A
- FBRX N/A
- EPS
- BNZI N/A
- FBRX N/A
- Revenue
- BNZI $9,021,543.00
- FBRX N/A
- Revenue This Year
- BNZI $337.60
- FBRX N/A
- Revenue Next Year
- BNZI $91.81
- FBRX N/A
- P/E Ratio
- BNZI N/A
- FBRX N/A
- Revenue Growth
- BNZI 107.94
- FBRX N/A
- 52 Week Low
- BNZI $2.08
- FBRX $4.11
- 52 Week High
- BNZI $112.00
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- BNZI 30.27
- FBRX 64.53
- Support Level
- BNZI $2.40
- FBRX $10.11
- Resistance Level
- BNZI $2.68
- FBRX $11.57
- Average True Range (ATR)
- BNZI 0.23
- FBRX 0.87
- MACD
- BNZI -0.03
- FBRX 0.06
- Stochastic Oscillator
- BNZI 2.74
- FBRX 96.73
About BNZI Banzai International Inc.
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).